Seroprevalence of parvovirus B19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis
Journal Title: Przegląd Epidemiologiczny - Year 2015, Vol 69, Issue 3
Abstract
INTRODUCTION AND OBJECTIVE. Acute parvovirus B19 (B19V) infection is a proven risk for pregnant women and fetus. The aim of this study was to determine the prevalence of B19V antibodies among pregnant women or planning pregnancy, who were referred for preventive toxoplasmosis screening. MATERIAL AND METHODS. Between 2007-2010, 55 women in the age between 21 and 40 years were tested for both B19V IgG and IgM antibodies and sociodemographic information was collected. RESULTS. Among the study group, the mean age was 30 years, 43.6% of women were positive only for B19V IgG antibodies, 9% were positive for both B19V IgG and IgM antibodies and 11% were positive only for B19V IgM antibodies. Women negative for B19 IgG antibodies (47.3% ) were considered as a high-risk group of B19V viremia. The serological profile indicating infection with Toxoplasma gondii was considered as a risk factor for fetal distress. The T. gondii IgG antibodies were detected in 51% cases, in 32.7% antibodies were positive for both IgG and IgM, while in 16.3% cases both IgG and IgM were negative. CONCLUSIONS. B19V infection and overlapping of other independent risk factors during pregnancy pose a significant hazard to fetus during development. Therefore, we recommend further broadening the epidemiological database of B19V infection prevalence among women. B19V infection should be taken into account during differential diagnosis as a cause of miscarriage.
Authors and Affiliations
Agata Zajkowska, Adam Garkowski, Piotr Czupryna, Anna Moniuszko, Monika E. Król, Jacek Szamatowicz, Sławomir Pancewicz
Keywords
Related Articles
- EP ID EP72154
- DOI -
- Views 92
- Downloads 0
Ocena skuteczności zastosowania wstępnej dawki rybawiryny w leczeniu przewlekłego zapalenia wątroby typu C
CEL PRACY. Celem pracy jest ocena skuteczności wstępnej dawki rybawiryny poprzedzającej 48-tygodniowe leczenie pegylowanym interferonem i rybawiryną u chorych wcześniej nieleczonych oraz po niepowodzeniu wcześniejszego l...
Różyczka w Polsce w 2013 roku
WSTĘP. Różyczka (łac. rubella) od 2004 r. podlega eliminacji w ramach programu koordynowanego przez Światową Organizację Zdrowia (WHO). Głównym celem Programu jest zahamowanie transmisji wirusa w środowisku oraz zapobieg...
Thiomersal-containing vaccines - a review of the current State of knowledge
Thiomersal is an organomercury compound known for its antiseptic and antifungal properties and used as an antibacterial agent in pharmaceutical products, including vaccines and other injectable biological products. In re...
Sexual behaviour and the risk of HCV infection
Review of measles-related events recorded by the National IHR Focal Point in Poland in the years 2016-2018 / Przegląd zdarzeń dotyczących odry odnotowanych przez Krajowy Punkt Centralny ds.Międzynarodowych Przepisów Zdrowotnych w Polsce w latach 2016-2018
Member States of the World Health Organization (WHO), in accordance with the requirements of the International Health Regulations (2005), were obliged to establish National Focal Points for International Health Regulatio...